English French Notes Complete/Exclude 528 FINE NEEDLE ASPIRATION...... 529 CORE NEEDLE BIOPSY.......... 530 INCISIONAL BIOPSY........... 531 EXCISIONAL BIOPSY........... 518OUTSIDE CONFIRMATION OF BIOPSY PRIMARY SITE..................: HISTOLOGY/BEHAVIOR CODE.......: 520ADDNL GRADE CODING SYSTEM..... 521VALUE OF ADDNL CODING SYSTEM.. 26DIAGNOSTIC CONFIRMATION....... PRETREATMENT TUMOR SIZE (mm) PATHOLOGIC TUMOR SIZE (mm) DEPTH OF TUMOR 29PRETREATMENT TUMOR SIZE (mm)... 522PATHOLOGIC TUMOR SIZE (mm)..... 523DEPTH OF TUMOR................. CONSULTATIONS: 524 MEDICAL ONCOLOGIST........... 525 RADIATION ONCOLOGIST......... TREATING SURGEON................: Not applicable, no surgery ASA CLASS.......................: Class unknown or not applicable POSTOPERATIVE DEATH.............: Not applicable, no surgery 526 TREATING SURGEON................ 527 ASA CLASS....................... 441 POSTOPERATIVE DEATH............. EXTERNAL BEAM RADIATION.........: No INTRAOPERATIVE RADIATION........: No EXTERNAL BEAM RADIATION.........: Unknown INTRAOPERATIVE RADIATION........: Unknown 532 EXTERNAL BEAM RADIATION......... 533 NUMBER OF FRACTIONS........... 534 RADIATION ENERGY (MV)......... 567 DATE THERAPY STARTED.......... 361 DATE THERAPY ENDED............ 535 INTRAOPERATIVE RADIATION........ 537 RADIATION ENERGY (MV)......... 539 NUMBER OF DAYS GIVEN.......... 541 DATE THERAPY STARTED.......... 542 DATE THERAPY ENDED............ 51.3 RADIATION/SURGERY SEQUENCE...... NUMBER OF FRACTIONS...........: 000 RADIATION ENERGY (MV).........: 00 DATE THERAPY STARTED..........: 00/00/0000 DATE THERAPY ENDED............: 00/00/0000 NUMBER OF FRACTIONS...........: 999 RADIATION ENERGY (MV).........: 99 DATE THERAPY STARTED..........: 99/99/9999 DATE THERAPY ENDED............: 99/99/9999 NUMBER OF DAYS GIVEN..........: 000 NUMBER OF DAYS GIVEN..........: 999 DATE OF CHEMOTHERAPY............: AGENTS ADMINISTERED, METHODS OF DELIVERY AND LOCATIONS: CISPLATIN.........: No DOXORUBICIN.......: No METHOD OF DELIVERY: Not applicable METHOD OF DELIVERY: Not applicable LOCATION..........: Not applicable LOCATION..........: Not applicable CYTOXAN...........: No ETOPOSIDE.........: No DTIC..............: No IFOSFAMIDE........: No METHOD OF DELIVERY..............: Not applicable LOCATION........................: Not applicable METHOD OF DELIVERY..............: Unknown 547 METHOD OF DELIVERY.............. 548 METHOD OF DELIVERY.............. 549 METHOD OF DELIVERY.............. 550 METHOD OF DELIVERY.............. 551 METHOD OF DELIVERY.............. 552 METHOD OF DELIVERY.............. 559 COLONY STIMULATING FACTORS...... 560 NATIONAL TREATMENT PROTOCOL..... 561 OTHER PROTOCOL.................. 562 REFERRED TO REHAB SERVICES...... 563 CONSULT W PHYSICAL THERAPY/REHAB 564 TRANSFERRED TO REHAB FACILITY... 565 NO OF HOSPITALIZATIONS W/I 6 MO. 566 TOTAL LENGTH OF STAYS........... DISTANT SITE(S) OF RECURRENCE SUBSEQUENT TREATMENT FOR RECURRENCE OR PROGRESSION TABLE V - FIRST RECURRENCE AND SUBSEQUENT TREATMENT NO SUBSEQUENT TREATMENT .07 HORMONE THERAPY ACCESSION NUMBER..................: SEQUENCE NUMBER...................: POSTAL CODE AT DIAGNOSIS..........: DATE OF BIRTH.....................: RACE..............................: SPANISH ORIGIN....................: SEX...............................: PRIMARY PAYER AT DIAGNOSIS........: FAMILY HIST OF SOFT TISSUE SARCOMA: PERSONAL HISTORY OF ANY CANCER....: CLASS OF CASE.....................: ANGIOGRAM OF PRIMARY............: BONE MARROW ASPIRATE/BIOPSY.....: BONE SCAN.......................: CT SCAN OF CHEST................: CT SCAN OF PRIMARY..............: LIVER FUNCTION STUDIES..........: MRI OF PRIMARY..................: MRI OF OTHER....................: ELECTRON MICROSCOPY.............: FLOW CYTOMETRY..................: IN SITU HYBRIDIZATION...........: BIOPSIES: HISTOLOGY/BEHAVIOR/GRADE FINE NEEDLE ASPIRATION..........: CORE NEEDLE ASPIRATION..........: INCISIONAL BIOPSY...............: EXCISIONAL BIOPSY...............: OUTSIDE CONFIRMATION OF BIOPSY....: DATE OF INITIAL DIAGNOSIS.........: PRIMARY SITE......................: SUBSITE...........................: HISTOLOGY/BEHAVIOR CODE...........: GRADE.............................: ADDNL GRADE CODING SYSTEM.........: VALUE OF ADDNL CODING SYSTEM......: DIAGNOSTIC CONFIRMATION...........: PRETREATMENT TUMOR SIZE (mm)......: PATHOLOGIC TUMOR SIZE (mm)........: DEPTH OF TUMOR....................: MULTIFOCAL........................: REGIONAL NODES EXAMINED...........: REGIONAL NODES POSITIVE...........: SITE OF DISTANT METASTASIS #1...: SITE OF DISTANT METASTASIS #2...: SITE OF DISTANT METASTASIS #3...: AJCC STAGE......................: CLINICAL STAGED BY..............: PATHOLOGIC STAGED BY............: MEDICAL ONCOLOGIST..............: RADIATION ONCOLOGIST............: Print Soft Tissue Sarcoma PCE PCE Study of Soft Tissue Sarcoma FIRST COURSE TREATMENT DATE.......: RESIDUAL PRIMARY TUMOR..........: TREATING SURGEON................: ASA CLASS.......................: POSTOPERATIVE DEATH.............: EXTERNAL BEAM RADIATION...: BRACHYTHERAPY...........: NUMBER OF FRACTIONS.......: NUMBER OF DAYS GIVEN....: DOSE....................: RADIATION ENERGY (MV).....: DATE THERAPY STARTED....: DATE THERAPY STARTED......: DATE THERAPY ENDED......: DATE THERAPY ENDED........: INTRAOPERATIVE RADIATION..: RADIATION/SURGERY SEQUENCE: DATE OF CHEMOTHERAPY: AGENT ADMINISTERED METHOD OF DELIVERY LOCATION COLONY STIMULATION FACTOR........: NATIONAL TREATMENT PROTOCOL......: OTHER PROTOCOL...................: REFERRED TO REHAB SERVICES.......: CONSULT W PHYSICAL THERAPY/REHAB.: TRANSFERRED TO REHAB FACILITY....: NO OF HOSPITALIZATIONS W/I 6 MO..: TOTAL LENGTH OF STAYS............: TYPE OF FIRST RECURRENCE..........: OTHER TYPE OF FIRST RECURRENCE....: DISTANT SITE(S) OF FIRST RECURRENCE: RECURRENCE SITE 1.................: RECURRENCE SITE 2.................: RECURRENCE SITE 3.................: NO SUBSEQUENT TREATMENT HORMONE THERAPY: SURGERY OF PRIMARY SITE DATE...: SCOPE OF LYMPH NODE SURGERY...: RECON/RESTORE - DELAYED.......: RECON/RESTORE - DELAYED DATE..: too long: Text should not exceed NAACCR length of Do you want to re-edit this field Patient Care Evaluation Study of Thyroid Cancer FAMILY HISTORY OF THYROID CANCER PERSONAL HISTORY OF NON-THYROID CANCER PRIOR EXPOSURE TO RADIATION PERSONAL HISTORY OF GOITER FAMILY HISTORY OF THYROID DISEASE PERSONAL HISTORY OF GRAVES DISEASE PERSONAL HISTORY OF THYROIDITIS FAMILY HISTORY OF GOITER OR OTHER THYROID DISEASE 9POSTAL CODE AT DIAGNOSIS.......... 9SPANISH ORIGIN.................... 18PRIMARY PAYER AT DIAGNOSIS........ 400FAMILY HISTORY OF THYROID CANCER.. PERSONAL HISTORY OF NON-THYROID CANCER: 402 CHILDHOOD MALIGNANCY............ 403PRIOR EXPOSURE TO RADIATION....... 404PERSONAL HISTORY OF GOITER........ 405FAMILY HISTORY THYROID DISEASE.... 406PERSONAL HISTORY OF GRAVES DISEASE 407PERSONAL HISTORY OF THYROIDITIS... SYMPTOMS/SIGNS PRESENT DIAGNOSTIC/SURGICAL WORKUP HISTOLOGY/BEHAVIOR CODE (ICD-O-2) BLOOD VESSEL INVASION EXTRA-THYROID EXTENSION SYMPTOMS/SIGNS PRESENT: 409 HOARSENESS OR VOICE CHANGE..... 410 NECK NODAL MASS................ 413 PATHOLOGIC FRACTURE............ 414 STRIDOR OR DIFFICULTY BREATHING 415 THYROID MASS................... 416 WEIGHT LOSS.................... DIAGNOSTIC/SURGICAL WORKUP: 418 BONE SCAN...................... 420 CT SCAN OF NECK................ 422 INCISIONAL BIOPSY.............. 425 NEEDLE ASPIRATION OF NECK NODE. 426 NEEDLE ASPIRATION OF THYROID... 427 MRI OF NECK.................... 428 THYROID SCAN................... 429 ULTRASOUND OF THYROID.......... HISTOLOGY/BEHAVIOR CODE (ICD-O-2): 431BLOOD VESSEL INVASION............ 432EXTRA-THYROIDAL EXTENSION........ SIZE OF TUMOR LOCATION OF POSITIVE NODES 29SIZE OF TUMOR.................. 434LOCATION OF POSITIVE NODES..... 19CLINICAL STAGE.................. 89PATHOLOGIC STAGE................ DATE OF FIRST COURSE TREATMENT.......: DATE OF NON CANCER-DIRECTED SURGERY: NON CANCER-DIRECTED SURGERY........: DATE OF SURGERY OF PRIMARY SITE....: DATE OF DISCHARGE AFTER SURGERY....: 00/00/0000 435 DATE OF DISCHARGE AFTER SURGERY.... SURGERY OF PRIMARY SITE............: RESIDUAL PRIMARY TUMOR.............: NA AIRWAY PROBLEM REQ TRACHEOSTOMY..: Not applicable, no surgery BLEEDING HEMATOMA................: Not applicable, no surgery HYPOCALCEMIA.....................: Not applicable, no surgery RECURRENT NERVE INJURY...........: Not applicable, no surgery WOUND INFECTION..................: Not applicable, no surgery POSTOPERATIVE DEATH WITH 30 DAYS.: Not applicable, no surgery 59 RESIDUAL PRIMARY TUMOR............. 436 AIRWAY PROBLEM REQ TRACHEOSTOMY.. 437 BLEEDING HEMATOMA................ 439 RECURRENT NERVE INJURY........... 440 WOUND INFECTION.................. 441 POSTOPERATIVE DEATH WITHIN 30 DAYS. RADIATION: DATE RADIATION STARTED.............: REGIONAL RAD (cGy) DOSE............: 00000 BOOST DOSAGE.......................: 00000 TOTAL MILLICURIES (mCi) OF RADIOIODINE: INITAL DOSE........................: 00000 SECOND DOSE........................: 00000 REGIONAL RAD (cGy) DOSE............: 99999 BOOST DOSAGE.......................: 99999 INITAL DOSE........................: 99999 SECOND DOSE........................: 99999 442 REGIONAL RAD (cGy) DOSE............ 443 BOOST DOSAGE....................... 444 INITIAL DOSE....................... 445 SECOND DOSE........................ ADJUVANT CHEMO W BEAM RADIATION....: No concomitant treatment ADJUVANT CHEMO W BEAM RADIATION....: Unknown if therapy concomitant 446 ADJUVANT CHEMO W BEAM RADIATION.... THYROID HORMONE THERAPY............: FAMILY HISTORY OF THYROID CANCER..: CHILDHOOD MALIGNANCY............: PRIOR EXPOSURE TO RADIATION.......: PERSONAL HISTORY OF GOITER........: FAMILY HISTORY OF THYROID DISEASE.: PERSONAL HISTORY OF GRAVES DISEASE: PERSONAL HISTORY OF THYROIDITIS...: TABLE II - INITIAL DIAGNOSIS/CANCER IDENTIFICATION HOARSENESS OR VOICE CHANGE......: NECK NODAL MASS.................: PATHOLOGIC FRACTURE.............: STRIDOR/DIFFICULTY BREATHING....: THYROID MASS....................: WEIGHT LOSS.....................: DIAGNOISTIC/SURGICAL WORKUP: CT SCAN OF NECK.................: NEEDLE ASPIRATION OF NECK NODE..: NEEDLE ASPIRATION OF THYROID....: MRI OF NECK.....................: THYROID SCAN....................: ULTRASOUND OF THYROID...........: PRIMARY SITE (ICD-O-2)............: HISTOLOGY/BEHAVIOR CODE (ICD-O-2).: BLOOD VESSEL INVASION.............: EXTRA-THYROIDAL EXTENSION.........: SIZE OF TUMOR (mm)................: LOCATION OF POSITIVE NODES........: CLINICAL STAGE................: PATHOLOGIC STAGE..............: Print Thyroid PCE PCE Study of Thyroid Cancer DISCHARGE AFTER SURGERY DATE....: AIRWAY PROBLEM W TRACHEOSTOMY.: BLEEDING HEMOTOMA.............: RECURRENT NERVE INJURY........: WOUND INFECTION...............: POSTOPERATIVE DEATH W/I 30 DAYS.: REGIONAL RAD (cGy) DOSE.........: BOOST DOSAGE....................: #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### ####################